查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197758

核甘酸市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Nucleotides Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內（2022 年至 2027 年），核甘酸市場的複合年增長率將超過 7%。

COVID-19 大流行對市場產生了積極影響，因為核甘酸在病毒性疾病的治療中得到了主要應用。

推動市場發展的主要因素是藥品對核甘酸的需求不斷增加。 另一方面，對水產飼料行業的滲透有限阻礙了市場增長。

在預測期內，藥用核甘酸預計將主導市場。

由於美國和加拿大等國家/地區的消費量不斷增加，北美地區是最大的市場，預計在預測期內將成為增長最快的市場。

核甘酸市場趨勢

食品和飼料添加劑領域有望主導市場

核甘酸在營養和生理功能中起著重要作用。 肌甘一磷酸（IMP）和鳥甘一磷酸（GMP）被廣泛用作食品中的適口性增強劑。 因此，核甘酸可以改善飼料的適口性。

此外，核甘酸影響腸上皮細胞的恢復，具有增強免疫力的作用。 參與免疫的組織細胞不能自我合成核甘酸。 因此，攝入核甘酸可以增強免疫力。

動物疾病的增加需要保持牲畜足夠的代謝率。 該行業的消費者意識也在不斷增強，這增加了對動物飼料的需求。

根據國際飼料工業聯合會的數據，全球複合飼料產量估計為每年 10 億噸。 全球商業飼料製造業的年銷售額估計超過 4000 億美元。

聯合國糧食及農業組織 (FAO) 估計，到 2050 年全球糧食產量將增加 60%，動物蛋白產量預計將進一步增加 - 到 2050 年肉類（家禽、豬肉和牛肉）將成為預計將翻一番，而奶製品和魚類產量預計將增長近兩倍。

因此，鑑於上述情況，預計食品和動物飼料添加劑領域將在預測期內主導市場。

中國有望主導亞太市場

中國是世界第二大醫藥市場。 由於中產階級的壯大、人口老齡化、收入的增加和城市化進程的推進，中國的醫藥市場正在迅速崛起。

到 2022 年底，該國的醫藥銷售額預計將達到 1750 億美元。 預計這將促進其在製藥行業使用方面研究的市場增長。

中國政府頒布了“健康中國 2030”藍圖，表明其繼續將健康作為可持續社會和經濟發展的先決條件。 由於該國積極的藥物研究，預計在預測期內對核甘酸的需求也將增加。

此外，COVID-19 大流行增加了該國的藥品需求和生產。 由於COVID-19疫情的影響，世界需要來自中國的藥品。

近年來，隨著飲食轉向動物蛋白，中國的畜牧業發展迅速。 今天，中國是世界上最大的畜牧生產國和最大的飼料生產國。

因此，從上述方面來看，中國有望在預測期內（2022-2027）主導亞太市場。

核甘酸市場競爭者分析

核甘酸市場高度整合，頂級參與者佔據市場主導份額。 頂級公司約佔總市場份額的80%。 市場上的主要參與者（排名不分先後）包括 CJ CheilJedang Corp.、Ajinomoto Co., Ltd.、Thermo Fisher Scientific Inc.、DAESANG、STAR LAKE BIOSCIENCE 等。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查先決條件
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 司機
    • 製藥行業對核甘酸的需求不斷增長
    • 其他司機
  • 約束因素
    • 對魚飼料行業的滲透有限
  • 工業價值鏈分析
  • 波特的五力分析
    • 新進入者的威脅
    • 買家的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭程度

第 5 章市場細分

  • 氮基
    • 嘧啶
    • 嘌呤體
  • 用法
    • 醫藥
    • 食品和飼料添加劑
    • 藥物發現
  • 地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 其他歐洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲
    • 中東
      • 沙特阿拉伯
      • 南非
      • 其他中東地區

第六章競爭格局

  • 併購、合資企業、合作、合同
  • 市場份額 (%)**/排名分析
  • 主要參與者採用的策略
  • 公司簡介
    • Ajinomoto Co. Inc.
    • CJ CHEILJEDANG CORP.
    • DAESANG
    • exoticbiosolutions.com
    • Jena Bioscience GmbH
    • MEIHUA HOLDINGS GROUP CO. LTD
    • Meridian
    • STAR LAKE BIOSCIENCE
    • Thermo Fisher Scientific Inc.

第七章市場機會與未來趨勢

  • 核甘酸補充劑在肉雞飼料中的用途
簡介目錄
Product Code: 71043

The nucleotides market is expected to register a CAGR of over 7% during the forecast period (2022-2027).

The impact of the COVID-19 pandemic was positive on the market, as nucleotides find major applications in treating viral diseases.

The major factor driving the market is the growing demand for nucleotides from pharmaceuticals. On the flip side, the limited penetration into the aquafeed industry is hindering the growth of the market.

Nucleotides from pharmaceutical applications are expected to dominate the market studied over the forecast period.

The North American region represents the largest market, and it is also expected to be the fastest-growing market over the forecast period, owing to the increasing consumption from countries like the United States and Canada.

Nucleotides Market Trends

The Food and Animal Feed Additives Segment is Expected to Dominate the Market

Nucleotides are vital in terms of nutritional and physiological functions. Inosine monophosphate (IMP) and guanosine monophosphate (GMP) are widely used as palatability enhancers in food. This helps nucleotides to enhance palatability for feed.

Also, nucleotides affect the recovery of intestinal epithelial cells, which helps boost immunity. Tissue cells involved in immunity cannot self synthesize nucleotides. Thus, immunity is strengthened by dietary nucleotides.

The rising incidences of animal diseases require maintaining adequate metabolism rates in livestock. Consumer awareness has also grown in this segment, which has increased the demand for animal feed.​

According to the International Feed Industry Federation, global compound feed production has reached an estimated 1 billion ton annually. Global commercial feed manufacturing generates an estimated annual turnover of over USD 400 billion. ​

The UN Food and Agricultural Organisation (FAO) estimates that the world will have to produce 60% more food by 2050, and it is believed that animal protein production will grow even more - meats (poultry/swine/beef) will double, and dairy and fish production will almost triple by 2050.

Hence, based on the aforementioned aspects, the food and animal feed additives segment is expected to dominate the market during the forecast period.

China is Expected to Dominate the Asia-Pacific Market

China is the second-largest market for pharmaceuticals globally. The market for pharmaceuticals is emerging rapidly due to the growing middle-class and aging population in the country, rising incomes, and increasing urbanization.

The pharmaceutical sales of the country are expected to reach up to USD 175 billion by the end of 2022. This is expected to boost the growth of the market studied in terms of its usage in the pharmaceutical industry.

The Chinese government promulgated Healthy China 2030, which is a blueprint outlining its ongoing intent to prioritize health as a precondition for sustained social and economic development. Additionally, the growing research in pharmaceuticals in the country is also expected to augment the demand for nucleotides during the forecast period.

Additionally, owing to the COVID-19 pandemic, the demand for and production of pharmaceuticals have increased in the country. The world is in need of pharmaceuticals from China due to the impact caused by the COVID-19 pandemic.

China's livestock industry has expanded rapidly in recent years as diets shift toward more animal proteins. At present, China is the world's largest producer of livestock products and the largest manufacturer of animal feed.

Hence, based on the aforementioned aspects, China is expected to dominate the Asia-Pacific market during the forecast period (2022-2027).

Nucleotides Market Competitor Analysis

The nucleotide market is highly consolidated, with the top players holding the lion's share in the market. The top players account for a share of around 80% of the total market. The key players in the market (in no particular order) include CJ CheilJedang Corp., Ajinomoto Co. Inc., Thermo Fisher Scientific Inc., DAESANG, and STAR LAKE BIOSCIENCE, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing Demand for Nucleotides from the Pharmaceutical Industry
    • 4.1.2 Other Drivers
  • 4.2 Restraints
    • 4.2.1 Limited Penetration into the Aquafeed Industry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Nitrogeneous Base
    • 5.1.1 Pyrimidine
    • 5.1.2 Purine
  • 5.2 Application
    • 5.2.1 Pharmaceutical
    • 5.2.2 Food and Animal Feed Additives
    • 5.2.3 Drug Discovery
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 France
      • 5.3.3.4 Italy
      • 5.3.3.5 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)**/Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Ajinomoto Co. Inc.
    • 6.4.2 CJ CHEILJEDANG CORP.
    • 6.4.3 DAESANG
    • 6.4.4 exoticbiosolutions.com
    • 6.4.5 Jena Bioscience GmbH
    • 6.4.6 MEIHUA HOLDINGS GROUP CO. LTD
    • 6.4.7 Meridian
    • 6.4.8 STAR LAKE BIOSCIENCE
    • 6.4.9 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Application of Nucleotide Supplements in Broiler Chicken Diets